Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$89,829,558
+$2,133,867 QoQ
Shares Held
201,168
+4.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Korea Investment CORP holds $256,163,456 across 7 Biotechnology names. VRTX ranks #1 (35.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
201,168 | $89,829,558 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
200,321 | $66,280,209 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
73,063 | $56,451,396 | |
| 4 | INCY |
Incyte Corp
|
220,926 | $20,793,555 | |
| 5 | RPRX |
Royalty Pharma plc
|
219,972 | $10,552,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
66,461 | $6,463,332 | |
| 7 | INSM |
INSMED Inc
|
35,429 | $5,793,350 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,829,558 | 201,168 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $87,695,691 | 193,435 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $80,577,971 | 205,745 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $89,811,976 | 201,734 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $107,232,487 | 221,180 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $83,402,391 | 207,108 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $103,036,613 | 221,546 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $100,681,056 | 214,800 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $99,811,173 | 238,777 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $123,222,160 | 302,839 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $97,485,779 | 280,341 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $124,847,462 | 354,771 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $116,569,598 | 369,980 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $103,461,499 | 358,271 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $103,080,293 | 356,014 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $85,861,131 | 304,699 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $65,818,982 | 252,209 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $49,123,861 | 223,697 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $26,407,844 | 145,586 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $45,608,907 | 226,201 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $47,659,808 | 221,787 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $35,978,274 | 152,231 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $52,464,736 | 192,800 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $54,520,218 | 187,800 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $43,187,925 | 181,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||